Connect with us

Health

ROBO Global Healthcare ETF Declines 0.7% Amid Low Trading Volume

editorial

Published

on

Shares of the ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC) experienced a decline of 0.7% on Friday, trading between $35.84 and $35.86. The price drop came as the ETF saw a total trading volume of only 2,509 shares, significantly below its average volume of 6,864 shares. The previous closing price stood at $36.10.

Performance Overview

The ETF’s performance over recent weeks shows a fifty-day simple moving average of $33.34 and a two-hundred-day simple moving average of $30.46. With a market capitalization of $53.79 million and a price-to-earnings ratio of -10,022.36, the ETF has a beta of 1.11, indicating a higher volatility compared to the market.

In terms of institutional trading, Flow Traders U.S. LLC recently made a noteworthy investment in the ROBO Global Healthcare ETF. The hedge fund acquired 45,631 shares valued at approximately $1,302,000 in the second quarter. This acquisition represents a 3.00% ownership stake in the ETF, as reported in their latest filing with the Securities and Exchange Commission (SEC). Overall, institutional investors and hedge funds collectively own 1.96% of the ETF.

About the Fund

The ROBO Global Healthcare Technology and Innovation ETF was launched on June 25, 2019, and primarily focuses on investing in equity within the healthcare sector. The fund tracks a proprietary index comprising global healthcare technology companies, aiming to provide investors with exposure to this dynamic industry.

For those interested in staying updated on the latest developments regarding the ROBO Global Healthcare ETF, a daily summary of news and analyst ratings can be received through a subscription to MarketBeat.com’s free email newsletter.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.